<DOC>
	<DOCNO>NCT02529488</DOCNO>
	<brief_summary>The purpose study investigate visual outcome assess safety 12 month ( 330-420 day ) post bilateral implantation AcrySof® IQ PanOptix™ Presbyopia-Correcting IOL .</brief_summary>
	<brief_title>Investigation AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens ( IOL ) Model TFNT00</brief_title>
	<detailed_description>This study conduct region test article approve time study start .</detailed_description>
	<mesh_term>Cataract</mesh_term>
	<mesh_term>Presbyopia</mesh_term>
	<criteria>Diagnosis bilateral cataract plan cataract removal phacoemulsification clear cornea incision ; Able comprehend willing sign inform consent complete require postoperative followup procedure ; Clear intraocular medium cataract eye ; Other protocolspecified inclusion criterion may apply . Clinically significant corneal abnormality include corneal dystrophy , inflammation edema ; Ocular trauma , corneal transplant , retinal condition , degenerative eye disorder , color vision deficiency ; Glaucoma ( uncontrolled control medication ) ocular hypertension ; Pregnant lactating ; Expected require ocular surgical retinal laser treatment ; Other protocolspecified exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>22 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>